APA (7th ed.) Citation

Topp, M. S., & Nagorsen, D. (2015). Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: A multicentre, single-arm, phase 2 study. The lancet. Oncology, 16(1), . https://doi.org/10.1016/S1470-2045(14)71170-2

Chicago Style (17th ed.) Citation

Topp, Max S., and Dirk Nagorsen. "Safety and Activity of Blinatumomab for Adult Patients with Relapsed or Refractory B-precursor Acute Lymphoblastic Leukaemia: A Multicentre, Single-arm, Phase 2 Study." The Lancet. Oncology 16, no. 1 (2015). https://doi.org/10.1016/S1470-2045(14)71170-2.

MLA (9th ed.) Citation

Topp, Max S., and Dirk Nagorsen. "Safety and Activity of Blinatumomab for Adult Patients with Relapsed or Refractory B-precursor Acute Lymphoblastic Leukaemia: A Multicentre, Single-arm, Phase 2 Study." The Lancet. Oncology, vol. 16, no. 1, 2015, https://doi.org/10.1016/S1470-2045(14)71170-2.